Results 221 to 230 of about 115,604 (298)
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown +7 more
wiley +1 more source
From intracranial aneurysm to subarachnoid hemorrhage : unraveling the genetics
Ynte M. Ruigrok
openalex +1 more source
ABSTRACT Background Neonatal alloimmune thrombocytopaenia (NAIT) is a rare but potentially serious condition where maternal antibodies result in destruction of foetal and neonatal platelets. At Middlemore Hospital in south Auckland, routine cord blood platelet counts were performed over many years.
Galama Vela +2 more
wiley +1 more source
ABSTRACT Background Since the introduction of electric scooters (e‐scooters), there has been a rise in related injuries and subsequent healthcare burden. There is a paucity of published research regarding paediatric e‐scooter injuries in Australia.
Rachel Cockburn +3 more
wiley +1 more source
Pre-Hospital Rate-Pressure Product Is Not Positively Associated with Hematoma Expansion or Initial Hematoma Volume in Spontaneous Intracranial Hemorrhage. [PDF]
Liang SQ +7 more
europepmc +1 more source
Bleeding Disorders in Children With Genetic Diseases: A Narrative Review
ABSTRACT Aim The lack of data on bleeding risk assessment in children with genetic diseases is concerning given their increased care needs and risk of haemorrhagic complications compared to the general population. Identification of haemostatic disorders is crucial for implementing preventive measures and mitigating bleeding risk.
Raphaelle Cagol +6 more
wiley +1 more source
Triple Vessel Disease With Intracranial Hemorrhage in a Patient With Guillain-Barre Syndrome: A Potential Complication, a Coincidental Finding or a Treatment-Related Adverse Event. [PDF]
Ghimire S +6 more
europepmc +1 more source
Summary Induction chemotherapy in fit de novo acute myeloid leukaemia (AML) patients has historically combined an anthracycline with standard‐dose cytarabine (‘7 + 3’) despite complete response (CR) rates of 50%–70%. In May 2023, our institution adopted the utilization of cladribine, cytarabine, idarubicin and venetoclax (CLIA‐VEN) for intensive ...
Benjamin J. Lee +11 more
wiley +1 more source
Summary Despite evidence‐based guidelines to inform platelet transfusion practice, unnecessary platelet transfusion persists. We performed a multicentre retrospective analysis of adults admitted to general medicine, subspecialty medicine and critical care from 1 January 2017 to 30 June 2022.
Sarah Ryan +14 more
wiley +1 more source

